NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.99% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 7.69% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 6.10% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.65% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.57% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.99% |
| 0QIU | Novo Nordisk A/S Class B | 4.67% | ||
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.21% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.99% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.57% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 3.36% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.25% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.91% |
| CSL | CSL Ltd | Healthcare | Biotechnology | 2.82% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.56% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.44% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.31% |